1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Vuno Inc.
  6. News
  7. Summary
    A338220   KR7338220007

VUNO INC.

(A338220)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Korean Ministry of Food and Drug Safety Designates the VUNO Inc.'s Artificial Intelligence-Based Electrocardiogram Analysis Software Vuno Med?-Deepecg? as the Ministry's 16th Breakthrough Device

11/02/2021 | 08:00am EDT

VUNO inc. announced that the Korean Ministry of Food and Drug Safety has designated the company's artificial intelligence-based electrocardiogram analysis software VUNO Med?-DeepECG? as the ministry's 16th Breakthrough Device. Using deep learning, the software analyzes ECG data to zero in on heart failure, myocardial infarction and arrhythmia. Although healthcare authorities such as the U.S. Preventive Services Task Force have pointed out the limitations of ECG tests on identifying cardiovascular diseases, the VUNO Med?-DeepECG? can pinpoint even minute differences in ECG data that escape visual analysis by learning the ECG data of patients suffering from heart failure, myocardial infarction and other major heart-related disorders. Through this learning process, the device provides additional information on heart failure undetected in previous ECGs to identify a myocardial infarction even if no major deflections in the ECG wave patterns can be seen. VUNO Med?-DeepECG?, once implemented in clinical practice, could help reduce mortality rates from major heart diseases and improve patient quality of life through early detection of symptomless patients through ECG testing and timely treatment.


ę S&P Capital IQ 2021
All news about VUNO INC.
02/263,818,929 Common Stock of Vuno Inc. are subject to a Lock-Up Agreement Ending on 26-FEB..
CI
2021Korean Ministry of Food and Drug Safety Designates the VUNO Inc.'s Artificial Intellige..
CI
2021VUNO Inc. Signs Another Deal with Samsung Electronics to Incorporate AI-Assisted Soluti..
CI
2021VUNO INC.(KOSDAQ : A338220) added to S&P Global BMI Index
CI
2021738,000 Common Stock of Vuno Inc. are subject to a Lock-Up Agreement Ending on 27-AUG-2..
CI
2021Vuno Inc. Received Regulatory Approval from the Ministry of Food and Drug Safety for it..
CI
2021VUNO Inks Deal with Samsung Electronics to Embed AI-powered Algorithms in Samsung's Pre..
CI
202154,000 Common Stock of Vuno Inc. are subject to a Lock-Up Agreement Ending on 27-MAY-20..
CI
20213,818,929 Common Stock of Vuno Inc. are subject to a Lock-Up Agreement Ending on 29-MAR..
CI
2021Vuno Inc. has completed an IPO in the amount of KRW 37.8 billion.
CI
More news
Financials
Sales 2020 1 257 M 0,98 M 0,98 M
Net income 2020 -11 109 M -8,66 M -8,66 M
Net cash 2020 1 849 M 1,44 M 1,44 M
P/E ratio 2020 -
Yield 2020 -
Capitalization 112 B 87,1 M 87,1 M
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees -
Free-Float 66,2%
Chart VUNO INC.
Duration : Period :
Vuno Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Hyun-Jun Kim Chief Executive Officer & Director
Sang-Jin Lee Chief Financial Officer & Director
Kyu Hwan Jung Chief Technology Officer & Director
Jong-Hoon Park Head-Information Technology
Hee-Kyo Jung Independent Director
Sector and Competitors
1st jan.Capi. (M$)
VUNO INC.-47.83%87
ACCENTURE PLC-30.82%181 640
SALESFORCE.COM, INC.-34.32%165 895
TATA CONSULTANCY SERVICES LTD.-8.65%161 316
INTERNATIONAL BUSINESS MACHINES CORPORATION-0.04%120 165
AUTOMATIC DATA PROCESSING, INC.-15.33%87 221